Peptide antiangiogenic drugs
    1.
    发明申请
    Peptide antiangiogenic drugs 审中-公开
    肽抗血管生成药物

    公开(公告)号:US20050124548A1

    公开(公告)日:2005-06-09

    申请号:US10764379

    申请日:2004-01-23

    IPC分类号: C07K7/06 A61K38/08

    CPC分类号: C07K7/06

    摘要: Peptides having the formula: A0-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10 wherein A0 is selected from hydrogen or an acyl group; A10 is a hydroxyl group or an amino acid amide; and A1, A2, A3, A4, A5, A6, A7, A8, and A9 are amino acyl residues as defined herein.

    摘要翻译: 具有以下结构式的肽:<?in-line-formula description =“In-line Formulas”end =“lead”?> A 1 > 2 3→3→3→3→5→ - →3→ > 7 -A “end =”tail“?>其中A 选自氢或酰基; A 10是羟基或氨基酸酰胺; 和A 1,A 2,A 3,A 4,A 5, A 6,A 7,A 8和A 9是如本文所定义的氨基酰基残基。

    TETRA-, PENTA-, HEXA- AND HEPTAPEPTIDES HAVING ANTIANGIOGENIC ACTIVITY
    9.
    发明申请
    TETRA-, PENTA-, HEXA- AND HEPTAPEPTIDES HAVING ANTIANGIOGENIC ACTIVITY 审中-公开
    具有抗炎活性的TETRA-,PENTA-,HEXA-和HEPTAPEPTID

    公开(公告)号:US20080071062A1

    公开(公告)日:2008-03-20

    申请号:US11620825

    申请日:2007-01-08

    IPC分类号: C07K16/00

    CPC分类号: C07K7/06 C07K7/08

    摘要: Compounds of formula (SEQ ID NO:2) and (SEQ ID NO:3), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.

    摘要翻译: 描述了可用于治疗由血管生成引起或加重的病症的式(SEQ ID NO:2)和(SEQ ID NO:3)的化合物。 还公开了包含这些化合物的药物组合物,使用这些化合物的治疗方法,以及抑制血管发生的方法。

    Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity
    10.
    发明申请
    Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity 审中-公开
    具有抗血管生成活性的六肽,七肽和八肽

    公开(公告)号:US20070167376A1

    公开(公告)日:2007-07-19

    申请号:US11460123

    申请日:2006-07-26

    IPC分类号: A61K38/10 C07K7/08

    CPC分类号: C07K7/06 A61K38/00

    摘要: Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.

    摘要翻译: 描述了可用于治疗由血管生成引起或加剧的病症的式(SEQ ID NO:1)的化合物。 还公开了包含这些化合物的药物组合物,使用这些化合物的治疗方法,以及抑制血管发生的方法。